{"schema_version":"secwatch.filing_event.v1","accession":"0000014272-26-000008","form_type":"8-K","ticker":"BMY","cik":"0000014272","company_name":"BRISTOL MYERS SQUIBB CO","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.271129+00:00","generated_at":"2026-05-15T00:37:17.321217+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bristol Myers Q1 revenue $11.5B (+3%); reaffirms 2026 guidance trending upper end","bullets":["Q1 revenue $11.5B, up 3% YoY (1% ex-FX); Growth Portfolio revenue $6.2B (+12% / +9% ex-FX).","GAAP EPS $1.31; non-GAAP EPS $1.58; both include $(0.03) net impact from Acquired IPRD and licensing.","FY 2026 guidance reaffirmed: revenue ~$46.0-47.5B, non-GAAP EPS $6.05-6.35, trending toward upper end.","CEO highlights strong execution and pipeline milestones ahead for patients and shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0000014272-26-000008","json":"https://secwatch.observer/filing/0000014272-26-000008.json","markdown":"https://secwatch.observer/filing/0000014272-26-000008.md","text":"https://secwatch.observer/filing/0000014272-26-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000008/0000014272-26-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000008/bmy-20260430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:37:17.321217+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8722ed5d878ae5e83292c1cd28ccc27d539c81ab","claim":"BRISTOL MYERS SQUIBB CO reported the first quarter of 2026 results: revenue $11,489, EPS $1.31. Guidance reaffirmed.","evidence_excerpt":"progress into meaningful outcomes for patients and shareholders.\" First Quarter Results $ in millions, except per share amounts 2026 2025 Change Change Excl. FX** Total Revenues $11,489 $11,201 3 % 1 % Earnings/(Loss) Per Share - GAAP* 1.31 1.20 9 % N/A Earnings/(Loss) Per Share - Non-GAAP* 1.58 1.80 (12) % N/A Acquired IPRD Charges and Licensing Income Net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000008/0000014272-26-000008-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter of 2026"},{"label":"Revenue","value":"$11,489"},{"label":"EPS","value":"$1.31"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}